BPS Position Statement on the medicinal use of cannabinoids in pain management

BPS Position Statement on the medicinal use of cannabinoids in pain management

29th Oct 2018

BPS Position Statement on the medicinal use of cannabinoids in pain management

The British Pain Society welcomes the increasing awareness and changes in government policies
towards the potential use of cannabinoid preparations for the management of various chronic
medical conditions including epilepsy, multiple sclerosis and pain management. Members of The
British Pain Society have occasionally come across patients who have benefited from using cannabis
and acknowledge that it may have a place in pain management for a small number of carefully
selected people. However, meta-analyses of clinical studies on cannabinoids for the management of
pain conclude that there is no positive evidence to support routine use in pain management. These...